Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month target […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $73.50, for a total transaction of $147,000.00. Following the transaction, the executive vice president now directly owns 69,423 shares […]
Ardevora Asset Management LLP lowered its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 28.5% during the third quarter, HoldingsChannel.com reports. The firm owned 140,253 shares of the medical research company’s stock after selling 55,847 shares during the period. Ardevora Asset Management LLP’s holdings in Exact Sciences were worth $9,568,000 at […]
MADISON, Wis., Jan. 2, 2024 /PRNewswire/ -- Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the...